COVID-19或流感ICU患者早期细菌合并感染:一项回顾性队列研究
该单中心回顾性倾向评分匹配队列研究纳入2015年1月至2022年4月ICU收治的COVID-19或流感患者,比较早期细菌合并感染(入ICU 2天内血或呼吸道培养阳性)率。289例COVID-19与39例流感患者中117例进入匹配分析(78 vs 39)。匹配队列中两组早期细菌合并感染率相似(18/78 [23%] vs 8/39 [21%];OR 1.16;95%CI 0.42-3.45;P=0.82),早期微生物检测频率与抗生素使用相似。在COVID-19总体组中,早期细菌合并感染与30天全因死亡率显著升高相关(21/68 [30.9%] vs 40/221 [18.1%];HR 1.84;95%CI 1.01-3.32)。
要点
- 匹配队列中COVID-19与流感ICU患者早期细菌合并感染率相似:18/78(23%)vs 8/39(21%),OR 1.16(95%CI 0.42-3.45),P=0.82。
- COVID-19总体组中,早期细菌合并感染与30天全因死亡率升高相关:21/68(30.9%)vs 40/221(18.1%),HR 1.84(95%CI 1.01-3.32)。
- 研究为单中心回顾性倾向评分匹配队列,纳入2015年1月至2022年4月ICU收治的COVID-19或流感患者。
适用人群与场景
- 纳入2015年1月至2022年4月单中心ICU收治的COVID-19或流感患者;共289例COVID-19和39例流感患者,其中117例(78例COVID-19 vs 39例流感)进入倾向评分匹配分析。
研究设计与关键结果
- 研究类型:单中心回顾性倾向评分匹配队列研究。
- 主要终点:匹配队列中COVID-19与流感组早期细菌合并感染(入ICU 2天内血或呼吸道培养阳性)率相似:18/78(23%)vs 8/39(21%);OR 1.16;95%CI 0.42-3.45;P=0.82。
- COVID-19总体组中,早期细菌合并感染与30天全因死亡率升高相关:21/68(30.9%)vs 40/221(18.1%);HR 1.84;95%CI 1.01-3.32。
证据类型、等级与局限
- 证据类型:回顾性倾向评分匹配队列研究;原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU中COVID-19与流感患者的早期细菌合并感染率可能相似,且COVID-19患者中早期细菌合并感染与30天死亡率升高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Previous findings suggest that bacterial coinfections are less common in ICU patients with COVID-19 than with influenza, but evidence is limited.
OBJECTIVES: This study aimed to compare the rate of early bacterial coinfections in ICU patients with COVID-19 or influenza.
DESIGN SETTING AND PARTICIPANTS: Retrospective propensity score matched cohort study. We included patients admitted to ICUs of a single academic center with COVID-19 or influenza (January 2015 to April 2022).
MAIN OUTCOMES AND MEASURES: The primary outcome was early bacterial coinfection (i.e., positive blood or respiratory culture within 2 d of ICU admission) in the propensity score matched cohort. Key secondary outcomes included frequency of early microbiological testing, antibiotic use, and 30-day all-cause mortality.
RESULTS: Out of 289 patients with COVID-19 and 39 patients with influenza, 117 (n = 78 vs 39) were included in the matched analysis. In the matched cohort, the rate of early bacterial coinfections was similar between COVID-19 and influenza (18/78 [23%] vs 8/39 [21%]; odds ratio, 1.16; 95% CI, 0.42-3.45; p = 0.82). The frequency of early microbiological testing and antibiotic use was similar between the two groups. Within the overall COVID-19 group, early bacterial coinfections were associated with a statistically significant increase in 30-day all-cause mortality (21/68 [30.9%] vs 40/221 [18.1%]; hazard ratio, 1.84; 95% CI, 1.01-3.32).
CONCLUSIONS AND RELEVANCE: Our data suggest similar rates of early bacterial coinfections in ICU patients with COVID-19 and influenza. In addition, early bacterial coinfections were significantly associated with an increased 30-day mortality in patients with COVID-19.
参考来源
- Bergmann F, Gabler C, Nussbaumer-Pröll A, et al. Early Bacterial Coinfections in Patients Admitted to the ICU With COVID-19 or Influenza: A Retrospective Cohort Study. Crit Care Explor. 2023. PMID: 37066070. doi:10.1097/CCE.0000000000000895
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。